PharmaCyte Biotech Inc. (PMCB)
PMCB trades on Nasdaq in Health Care, Biotechnology: Biological Products (No Diagnostic Substances). Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$0.3559
-2.52% on the day
Market cap
$3.8M
Nano cap
Revenue · 2025
$0
Prior year not contiguous
Net income · 2025
-$19.4M
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | PMCB on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0001157075 |
| SEC industry code | Biological Products, (No Diagnostic Substances) |
| Incorporated in | NV |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $0 |
| Net income | -$19.4M |
| Operating income | -$6.9M |
| Net margin | Needs revenue and net income |
| Operating margin | Operating income not reported |
| Revenue growth | No prior-year revenue to compare |
| Cash | $20.2M |
| Total assets | $55.9M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | Needs market cap and revenue |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document FORM S-3 | S-3 | 2025-09-17 |
| Latest annual report FORM 10-K FOR APRIL 2026 | 10-K | 2026-07-29 |
| Latest quarterly / interim FORM 10-Q FOR JUL 2026 | 10-Q | 2026-09-14 |
| Latest current report FORM 8-K | 8-K | 2026-04-02 |
| Latest proxy DEFINITIVE PROXY STATEMENT | DEF 14A | 2026-03-09 |
Source: SEC EDGAR submissions feed, 471 recent filings. All filings on EDGAR.
Peers in Biotechnology: Biological Products (No Diagnostic Substances)
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| CLDI | Calidi Biotherapeutics Inc. | $0.8999 | -5.26% | $3.3M |
| LIMN | Liminatus Pharma Inc. | $3.41 | -1.16% | $4.6M |
| VIVS | VivoSim Labs Inc. | $0.1742 | +0.12% | $2.9M |
| SLXN | Silexion Therapeutics Corp | $0.1760 | -1.24% | $2.5M |
| BTTC | Black Titan Corporation | $0.4380 | -10.70% | $6.0M |
| HLSQ | Tessera Defense and Homeland Security Inc. | $0.2600 | -7.08% | $2.3M |
| CELZ | Creative Medical Technology Holdings Inc. | $0.8199 | -2.51% | $6.2M |
| AIM | AIM ImmunoTech Inc. | $0.1699 | -4.23% | $6.8M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier